about
Interventions for chronic non-hypovolaemic hypotonic hyponatraemiaDrinking extra water or other non-caloric beverages for promoting weight loss or preventing weight gainEfficacy and Safety of Vasopressin Receptor Antagonists for Euvolemic or Hypervolemic Hyponatremia: A Meta-AnalysisThiazide-associated hyponatremia in the elderly: what the clinician needs to knowDiagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statementsRole of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectivesPhysiopathology, clinical diagnosis, and treatment of hyponatremia.Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure.[Hyponatremia: differential diagnosis and therapy].Regional differences in osmotic behavior in brain during acute hyponatremia: an in vivo MRI-study of brain and skeletal muscle in pigs.Individuality of the plasma sodium concentrationMineralocorticoid responsive hyponatremia of the elderly: A systematic review.Extrapontine myelinolysis associated with pituitrin: case report and literature review.Clinical practice guideline on diagnosis and treatment of hyponatraemia.Are we being drowned in hydration advice? Thirsty for more?Vacuolar pathology in the median eminence of the hypothalamus after hyponatremia.Diagnosis and management of hyponatraemia: AGREEing the guidelinesShort-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia.Osmotic myelinolysis: Does extrapontine myelinolysis precede central pontine myelinolysis? Report of two cases and review of literature.Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): therapeutic decision-making in real-life cases.Prevalence of Hyponatremia in Palliative Care Patients.Experience with Tolvaptan for Euvolemic and Hypervolemic Hyponatremia in the Acute Care Setting.Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study.Preparation for radioactive iodine therapy is not a risk factor for the development of hyponatremia in thyroid cancer patients.Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study.Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).Initial approach to the hyponatremic patient.The therapeutic use of vaptans for the treatment of dilutional hyponatremia.Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.Significance of hypo- and hypernatremia in chronic kidney disease.Update on tolvaptan for the treatment of hyponatremia.Prevalence of hyponatremia in inpatients with incurable and life-limiting diseases and its association with physical symptoms-a retrospective descriptive study.Electrolyte and acid-base abnormalities associated with purging behaviors.Hyponatremia as an independent prognostic factor in patients with terminal cancer.Tolvaptan for the treatment of hyponatremia and hypervolemia in patients with congestive heart failure.Syndrome of inappropriate antidiuretic hormone secretion associated with pramipexole in a patient with Parkinson's disease.Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients.SIADH and hyponatraemia: foreword.Syndrome of inappropriate antidiuretic hormone secretion associated with pramipexole in a patient with Parkinson's disease.Hyponatremia in the elderly: challenges and solutions.
P2860
Q24200705-28CF3C83-6E22-4CF4-9182-2C4D241C827EQ26472041-AA1DFBEB-19D3-4BC1-951A-36FE86077909Q26747663-8A4312FC-CBED-425E-8881-69B64F189140Q26750662-7D220CB5-11D9-49B3-8570-57E0E52CF9F0Q27016147-E2654B46-367C-4FB5-9BAA-38210196A97DQ28072768-215DBE94-BFDA-4C31-B22B-90926EB89404Q30240732-34FB4F8D-7E65-4A2A-9C96-39BBD473A3F4Q30422457-65ED8561-8A95-4EC3-A4A0-9372266AF532Q33164946-3EB3D32D-5C39-4D92-A54D-9EA4A674E4DAQ33571738-47381548-DB15-4E2B-8F89-0AE5ECC4F1F1Q33764556-D76277CC-4F62-40BC-9557-5B80FE0DDCB4Q33885720-01A8B67A-D6D2-4CAC-B058-A4BE2BC97037Q34340130-B01119CB-E929-41D2-A760-4C35098ABF87Q34406779-C6822DD0-2CF6-4162-95BE-85FA1BC64539Q34419238-3EA0FF4C-E22A-4A4F-8AE0-38AF83DCC5C8Q34779598-97B6CF4E-AAAC-4DC2-B912-A8CD5ED0FD0EQ35084239-308AD3D3-68E0-4FE9-A638-56665627AED1Q35275760-9E6B7CC8-FB85-4781-8152-1796853A2A8EQ35568744-6EB1DC50-38B9-4F50-A0B0-522669939B06Q35626444-E6C0D5C4-7F3A-48D2-9183-B8CBA7557BE0Q35951966-2AB19727-086B-41E0-BFC1-8F95DA4514DDQ36052267-951CCD77-D5E7-454F-B4C2-E5F89586A557Q36785625-0916A3DB-AB1B-4CAB-8E77-E5FBDD80AEA2Q37626655-E47BAF59-FB64-4746-9679-AAE2409D810EQ37678174-DB3CAF71-5650-4E73-95E8-D80C40426A8FQ37799214-F5683614-0C1C-43B6-9D8C-D5722961BB09Q37804404-F6A32F0C-A6CE-405C-9931-EAB91A315D43Q37911141-52FE7158-5050-46C8-BA60-F9D736B08E80Q37959051-0845493C-3C36-4B08-B10B-E331F47B6808Q37989443-3F8EBD8D-210F-40F2-AA82-5593F3F5B56FQ38042707-FA344216-A498-44B6-81B2-4E388AA8C002Q38617856-353366F4-0A31-4834-9E76-1C286EC6B373Q38733202-F1261225-AA53-40D6-99CF-339C95DC7C58Q39092737-FCDB306E-799E-4F8E-A2CC-97B93909776AQ39456742-28B6A741-8C41-4216-AD21-378D16EC56E6Q39783880-8107844D-F6FB-43CA-92CE-ABED7FF2128BQ41295884-544F4ADE-9BE1-48B5-9EEE-4A1133859450Q42013491-685F6E8B-AF01-4AA3-8DDD-D98CDA7563FFQ42118723-474B9C1A-61D4-4459-BB6B-468B68B3B505Q46064949-2BD3E890-BE8C-4D9E-9CB1-640D1D77A74B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiology of hyponatremia.
@en
Epidemiology of hyponatremia.
@nl
type
label
Epidemiology of hyponatremia.
@en
Epidemiology of hyponatremia.
@nl
prefLabel
Epidemiology of hyponatremia.
@en
Epidemiology of hyponatremia.
@nl
P1476
Epidemiology of hyponatremia
@en
P2093
Bertrand L Jaber
Nicolaos E Madias
P304
P356
10.1016/J.SEMNEPHROL.2009.03.004
P577
2009-05-01T00:00:00Z